New products are an essential component of our range. Introductions are made on an ongoing basis, with hundreds of new small molecules, peptides and antibodies being added every year. Our aim is to find the latest, otherwise unobtainable research tools, and bring them to the market as quickly as we can.
| Cat.No. | Product Name | Activity |
| 5796 | Azoramide | Unfolded protein response (UPR) modulator |
| 5765 | 4-azido-N-ethyl-1,8-naphthalimide | Click-activated fluorescent probe |
| 5681 | N106 | Activator of SUMO-activating enzyme, E1 ligase |
| 5301 | BPTES | Selective allosteric glutaminase (GLS1) inhibitor |
| 5039 | SR 144528 | High affinity and selective CB2 inverse agonist |
| 4568 | CPYPP | DOCK2-Rac1 interaction inhibitor |
| 5668 | VUF 11222 | High affinity non-peptide CXCR3 agonist |
| 5592 | LCB 03-0110 dihydrochloride | Potent c-SRC kinase inhibitor; also inhibits DDR2, BTK and Syk |
| 5100 | TC-T 6000 | Potent equilibrative nucleoside transporter 4 (ENT4) inhibitor |
| 5083 | QO 58 | Kv7 channel opener |
| 4968 | CCT 241533 dihydrochloride | Potent Chk2 inhibitor |
| 4180 | Beraprost sodium | Potent prostacyclin IP receptor agonist |
| 5823 | Ala-Gln | Stable form of L-glutamine; commonly used in cell culture |
| 5819 | Bexarotene | Potent and selective RXR agonist |
| 5792 | ProTx III | Potent Nav1.7 blocker; analgesic |
| 5646 | EML 425 | Reversible and non-competitive p300/CBP inhibitor |
| 5790 | PF 05175157 | Acetyl-CoA carboxylase (ACC) 1 and 2 inhibitor |
| 5769 | TM 5275 sodium salt | Plasminogen activator inhibitor-1 (PAI-1) inhibitor; orally bioavailable |
| 5666 | JNJ 63533054 | Potent and selective GPR139 agonist |
| 5665 | IRAK1/4 Inhibitor I | IRAK4 and IRAK1 inhibitor |
| 5660 | NVP CXCR2 20 | Potent and selective CXCR2 antagonist |
| 5557 | Dianicline | Selective α4β2 nAChR partial agonist |
| 5798 | Irbesartan | Potent AT1 antagonist |
| 5772 | Sacubitril calcium | Membrane metallo-endopeptidase (neprilysin) inhibitor prodrug; orally bioavailable |
| 5759 | SW 033291 | High affinity 15-PGDH inhibitor; promotes hematopoiesis and hepatocyte proliferation |
| 5694 | GSK 2033 | Potent LXR antagonist |
| 5687 | Centrinone | High affinity and selective PLK4 inhibitor |
| 5661 | 666-15 | Potent and selective CREB inhibitor |
| 5615 | AZD 3147 | Potent and selective dual mTORC1 and 2 inhibitor; orally bioavailable |
| 4707 | MI 2 dihydrochloride | Menin-MLL interaction inhibitor |